Clinical Trial Update: Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on autologous endothelial progenitor cell transplantation for chronic ischemic stroke (Phase 1/Phase 2) have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Southern Medical University, China | Conditions: Stroke | Phase 1, Phase 2 | Status: COMPLETED